Ian F. Smith
2016
In 2016, Ian F. Smith earned a total compensation of $5.8M as EVP & Chief Operating Officer and CFO at Vertex Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $562,500 |
|---|---|
| Option Awards | $1,305,144 |
| Salary | $750,000 |
| Stock Awards | $3,150,148 |
| Other | $12,885 |
| Total | $5,780,677 |
Smith received $3.2M in stock awards, accounting for 54% of the total pay in 2016.
Smith also received $562.5K in non-equity incentive plan, $1.3M in option awards, $750K in salary and $12.9K in other compensation.
Rankings
In 2016, Ian F. Smith's compensation ranked 1,294th out of 14,075 executives tracked by ExecPay. In other words, Smith earned more than 90.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,294 out of 14,075 | 91st |
Division Manufacturing | 434 out of 5,489 | 92nd |
Major group Chemicals And Allied Products | 115 out of 1,895 | 94th |
Industry group Drugs | 77 out of 1,538 | 95th |
Industry Pharmaceutical Preparations | 62 out of 1,176 | 95th |
Source: SEC filing on April 28, 2017.
Smith's colleagues
We found five more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2016.
2016
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2016
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2016
Stuart Arbuckle
Vertex Pharmaceuticals
EVP & Chief Commercial Officer
2016
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2016
David Altshuler
Vertex Pharmaceuticals